1066.HK - Shandong Weigao Group Medical Polymer Company Limited

HKSE - HKSE Delayed Price. Currency in HKD
5.220
+0.060 (+1.163%)
As of 3:40PM HKT. Market open.
Stock chart is not supported by your current browser
Previous Close5.160
Open5.160
Bid5.210 x 0
Ask5.220 x 0
Day's Range5.150 - 5.340
52 Week Range4.500 - 6.530
Volume6,438,855
Avg. Volume3,797,624
Market Cap23.607B
BetaN/A
PE Ratio (TTM)18.79
EPS (TTM)0.278
Earnings DateMar 20, 2018 - Mar 26, 2018
Forward Dividend & Yield0.10 (1.96%)
Ex-Dividend Date2017-06-15
1y Target Est6.43
  • Best-In-Class Undervalued Stocks
    Simply Wall St.10 days ago

    Best-In-Class Undervalued Stocks

    Companies with shares trading at a market price below what they are actually worth, such as Hua Hong Semiconductor and Shandong Weigao Group Medical Polymer, are deemed undervalued. Investors canRead More...

  • Shandong Weigao Group Medical Polymer Co. Ltd. : Overvalued relative to peers, but may deserve another look
    Capital Cube2 months ago

    Shandong Weigao Group Medical Polymer Co. Ltd. : Overvalued relative to peers, but may deserve another look

    Categories: Yahoo FinanceShandong Weigao Group Medical Polymer Co. Ltd. relative valuation is now OVERVALUED. It was previously rated NEUTRAL, and has a fundamental analysis score of 47. Our analysis is based on comparing Shandong Weigao Group Medical Polymer Co. Ltd. with the following peers – LifeTech Scientific Corporation, PW Medtech Group Ltd., Nanjing Sinolife United Co., Ltd. ... Read more (Read more...)

  • Reuters3 months ago

    BRIEF-Shandong Weigao Group Medical Polymer says Nikkiso Agreed To Subscribe For Additional Capital In Unit ​

    Dec 4 (Reuters) - Shandong Weigao Group Medical Polymer Co Ltd: * SHANDONG WEIGAO GROUP MEDICAL POLYMER CO - ‍XIA LIE BO HAS RESIGNED AS AN EXECUTIVE DIRECTOR WITH EFFECT FROM 4 DEC 2017​ * ‍ NIKKISO AGREED ...

  • Shandong Weigao to Buy Argon in China's Latest U.S. Health Deal
    Bloomberg5 months ago

    Shandong Weigao to Buy Argon in China's Latest U.S. Health Deal

    Shandong Weigao Group Medical Polymer Co. agreed to buy closely held Argon Medical Devices Inc. for $850 million, continuing a string of deals by Chinese companies seeking to gain a foothold in the U.S. ...

  • Reuters5 months ago

    Chinese medical devices maker to buy US-based Argon for $850 mln

    China's Shandong Weigao Group Medical Polymer Co Ltd has agreed to acquire US-based and unlisted Argon Medical Devices Holdings Inc for $850 million, as part of its overseas expansion drive. Weigao Group, mainly engaged in the production and sale of medical devices, orthopaedic and blood purification products, has been seeking opportunities to bolster its product portfolio, the company said in a filing to the Hong Kong Stock Exchange. The company has also been looking to diversify its revenue stream to increase the contribution of sales from overseas markets, and expects "significant growth opportunities" for Argon Medical's products in China.

  • PR Newswirelast year

    Misonix, Inc. Enters into Exclusive Chinese Distribution Agreement for BoneScalpel

    FARMINGDALE, N.Y., March 7, 2017 /PRNewswire/ -- Misonix, Inc. (MSON), a provider of minimally invasive therapeutic ultrasonic medical devices that enhance clinical outcomes, today announced that it has entered into an exclusive distribution agreement with Shandong Weigao Orthopedic Device Company Limited ("Weigao Orthopedic"), a subsidiary of Shandong Weigao Group Medical Polymer Company Limited (1066.HK).Weigao Orthopedic is a medical device company in China specializing in research and development, production and sale of spine, trauma and joint orthopedic implants devices. Mr. Stavros Vizirgianakis, President and Chief Executive Officer of Misonix, said, "We are pleased to enter into this distribution agreement with Weigao Orthopedic, one of the most highly regarded orthopedic and spine surgery device providers in the People's Republic of China.